P}HMBC spectrum of MPIase. A cross peak between the phosphorus signal at -13.0 ppm and an anomeric proton at 5.5 ppm indicated that the reducing terminal of the glycan is linked to a pyrophosphate moiety. The other phosphorus atom at -11.3 ppm is correlated with a methylene signal at 4.1 ppm.
Supplementary Figure S17. MALDI-FT-ICR-MS spectrum of NaOH-MPIase. (a)
The mass detection was focused on the middle-high mass range around 3 kDa to pick up fragment ions of a glycan moiety (arrows: n = 3~6). The mass difference of 607. The membrane-spanning region is italicized. Amino acids with positive and negative charges are shown in blue and red, respectively. The insertion of 3 leucine residues into Pf3 coat, which renders its membrane insertion independent of a membrane potential 10, 20 , is shown in bold. (c) Scheme of the integration assay for 3L-Pf3 coat. 3L-Pf3 coat was in vitro synthesized in the presence of liposomes or INV using the pure system 11, 39, 40 . Upon proteinase K treatment, a membrane-protected fragment (MPF) was generated as a result of membrane integration, followed by determination of the integration activity. Figure S20 . The effect of the cytosol on 3L-Pf3 integration into liposomes. (a) An E. coli S30 fraction, obtained from the Roche RTS translation system, was dialyzed against 50 mM Hepes-KOH (pH 7.5), was added to the 3L-Pf3 coat integration reaction at 3.5 mg/ml. DAG-containing liposomes in which MPIase had been reconstituted (+, 2.9 M) or not reconstituted (-) were used. Anti-MPIase IgG (MPIase IgG, 1 mg/ml) was added as specified. (b) 3L-Pf3 coat integration into DAG-containing (left) and -lacking (right) liposomes was analyzed in the presence and absence of the S30 fraction as in (a). The amounts of DAG-lacking liposomes were reduced to 0.1 mg/ml, since saturated spontaneous integration activity was observed at 0.4 mg/ml. The integration activities were determined and are shown. (c) 3L-Pf3 coat was in vitro synthesized in the presence (bottom) and absence (top) of S30 as in (a). After 1-h translation, the reaction mixture (50 l) was applied to a Superose 6 column, which had been equilibrated with 50 mM Hepes-KOH (pH 7.5). The column was developed at 1.0 ml/min and 0.5 ml fractions were collected from 5 min after the start. An aliquot of each fraction (100 l) was precipitated with TCA (5%), followed by analysis by SDS-PAGE/autoradiography. The position of 3L-Pf3 coat is indicated. (d) The amount of 3L-Pf3 coat in each fraction in (c) was determined and is plotted as a percentage of the total amount. The sum of fractions 10~26 under each condition, which corresponds to soluble fractions, was calculated and is shown in the inset. The 13 C-NMR chemical shifts of HF-MPIase are well consistent with those of (I) and (III)
Supplementary

as well as those of ECA previously reported 18, 19, 31 . The asterisks show the positions where the next sugar is linked in MPIase.
Supplementary Methods
Syntheses of authentic sugars (10, 12~14) and disaccharides (I~III)
General methods. All chemicals were reagent grade and purchased from Nacalai tesque.
Unless otherwise noted, all chemicals and solvents were used as supplied. Molecular sieves were activated on micro wave for 2 min, followed by being dried in vacuo. 4, 68.4, 68.9, 73.5, 75.3, 78.5, 79.1, 82.1, 96.7, 101.1, 118.3, 125.9, 127.5, 127.8, 127.9, 128.0, 128.1, 128.2, 128.3, 128.8, 133.5, 137.3, 138 6, 68.6, 68.9, 71.2, 72.6, 79.7, 96.4, 101.4, 118.2, 126.1, 127.8, 127.9, 128.1, 128.3, 128.4, 128.8, 129.8, 130 
Allyl 3-O-benzoyl-2-O-benzyl--D-glucopyranoside (3b).
In the same manner as 3a, 3b (642 mg, 85%) was obtained from 2b (917 mg, 1.83 mmol). 71.4, 72.6, 76.1, 76.5, 77.2, 95.4, 118.1, 127.8, 127.9, 128.3, 128.3, 129.6, 129.8, 133.3, 133.5, 137.6, 167.6 .
Allyl 2,3-di-O-benzyl-4,6-bis-O-(methanesulfonyl)--D-glucopyranoside (4a).
44
To an ice-cold solution of 3a (196 mg, 0.49 mmol) in pyridine (10 ml), MsCl (100 l, 1.47 mmol) was added and the mixture was stirred at room temperature overnight. The reaction was quenched with MeOH. The mixture was concentrated, which was extracted 
Allyl 3-O-benzoyl-2-O-benzyl-4,6-bis-O-(methanesulfonyl)--D-glucopyranoside (4b).
In the same manner as 4a, 4b (870 mg, 75%) was obtained from 3b (840 mg, 2.03 mmol). 5, 38.7, 67.0, 67.1, 69.0, 71.2, 72.8, 74.2, 76.4, 95.2, 118.7, 127.8, 128.0, 128.4, 128.5, 129.3, 129.8, 132.9, 133.4, 137.0, 165.4 
Allyl 2,3-di-O-benzyl-6-deoxy-6-iodo-4-O-(methanesulfonyl)--D-glucopyranoside (5a).
44
A suspension of NaI (900 mg, 6.0 mmol) and the compound 4a (860 mg, 1.54 mmol) in 2-butanone (30 ml) was heated under reflux for 3 h. The mixture was cooled to room temperature and extracted with AcOEt. The combined organic phase was washed with 10% aqueous Na 2 S 2 O 3 , brine, and dried over MgSO 4 . The obtained crude product was purified by flash column chromatography (hexane : AcOEt = 5 : 1) to give the desired product 5a (845 mg, 93%). 3, 38.8, 68.5, 68.6, 70.9, 72.7, 78.5, 94.8, 118.7, 127.8, 128.0, 128.4, 128.5, 129.3, 129.8. 132.9, 133.4, 137.1, 165.4 4, 38.8, 65.2, 68.6, 71.4, 72.5, 80.7, 94.9, 118.2, 127.8, 128.3, 128.5, 129.6, 129.8, 133.3, 133.4, 137.3, 165.4 
Allyl 4-azido-2,3-di-O-benzyl-4-deoxy--D-fucopyranoside (7a).
44 NaN 3 (500 mg, 7.7 mmol) was added to a solution of 6a (122 mg, 0.26 mmol) in DMF (5 ml). The mixture was heated at 110 °C overnight, followed by being cooled to room temperature and extracted with AcOEt. The combined organic phase was washed with brine and dried over MgSO 4 . The obtained crude product was purified by flash column chromatography (hexane : AcOEt = 10 : 1) to give the desired product 7a (61 mg, 57%) and the recovered 6a (25 mg, 20%). 64.4, 64.9, 68.5, 72.4, 73.0, 73.4, 96.0, 117.9, 127.8, 128.3, 128.4, 129.3, 129.9, 137.8, 165.7; 64.7, 65.8, 68.5, 69.7, 72.7, 95.4, 117.8, 128.1, 128.4, 133.6, 137.7 
4-Azido-2,3-di-O-benzyl-4-deoxy--D-fucopyranosyltrichloroacetimidate (11).
A solution of (1,5-cyclooctadiene)bis(methyldiphenylphosphine)iridium(I) hexafluorophosphate (42 mg, 0.05 mmol) 45 in THF (10 ml) was stirred under H 2 until the solution became clear. After purging H 2 , a solution of 7a (205 mmol, 0.50 mmol) in THF (10 ml) was added to the stirred solution, followed by being stirred for 1.5 h at room temperature.
Aqueous sat. NaHCO 3 (2.0 ml) and I 2 (635 mg, 2.50 mmol) were added to the mixture, which was stirred for 1 h at room temperature. The mixture was diluted with AcOEt and was washed with aqueous 5% Na 2 S 2 O 3 and brine. The combined organic phase was dried over MgSO 4 . The obtained crude product was purified by flash column chromatography (hexane : AcOEt = 4 : 1 → 2 : 1) to give the alcohol (154 mg, 83%). To a solution of the alcohol (48 mg, 0.13 mmol) in CH 2 Cl 2 (2.0 ml) CCl 3 CN (130 l, 1.3 mmol) and CsCO 3 (21 mg, 0.065 mmol) were added. After being stirred for 2 h at room temperature, aqueous sat. NaHCO 3 was added to the mixture, which was extracted with AcOEt. The combined organic phase was washed with brine and dried over MgSO 4 . The solvent was removed to give the desired product 11 as a ca. 2:3 mixture of -isomers (65 mg, 97%). 69.5, 69.6, 70.8, 96.7, 127.5, 127.8, 127.9, 137.2, 169.7, 172.3 7, 68.7, 68.9, 72.3, 74.8, 78.9, 81.8, 97.9, 101.2, 118.2, 125.9, 127.6, 127.8, 128.2, 128.3, 128.9, 133.3, 137.2, 138.4 mmol) in DMF (9 ml) was stirred at 70 °C for 2.5 h. After cooling the mixture to room temperature, water was added to the mixture, which was extracted with AcOEt. The 
Methyl (benzyl 2-acetamido-2-deoxy--D-glucopyranosid)uronate (12).
Methyl (benzyl 2-acetamido-2-deoxy--D-mannopyranosid)uronate (13
Methyl (benzyl 2-acetamido-2-deoxy--D-galactopyranosid)uronate (14)
.
Allyl 3-O-benzyl-4,6-O-benzylidene--D-glucopyranoside (15).
Allyl 2-azido-3-O-benzyl-4,6-O-benzylidene-2-deoxy--D-mannopyranoside (16).
In the same manner as 16, 16 (2.20 g, 73 %) was obtained from 15 (3.66 g, 14.3 mmol). 
Allyl 2-azido-3-O-benzyl-2-deoxy--D-mannopyranoside (17).
In the same manner as 17, 17 (2.14 g, 87%) was obtained from 16 (3.09 g, 7.3 mmol). in aqueous NaHCO 3 (1.5 ml) was added to the mixture, followed by being cooled to 0 -5 °C. Ca(OCl) 2 (27 mg, 0.19 mmol) was added to the mixture, which was stirred at the same temperature for 2.5 h. After addition of MeOH and water, the mixture was 21.4, 21.5, 61.9, 62.2, 64.4, 65.5, 68.5, 68.9, 69.2, 72.4, 73.5, 75.0, 75.1, 95.6, 96.4, 118.8, 128.7, 129.0, 129.2, 134.4, 138.4, 170.5, 170.6, 171.3; 
Propyl (2-acetamido-2-deoxy--D-glucopyranosyl)-(1→3)-4-acetamido-4-deoxy--D-fucopyranoside (III)
. NaOMe (1.0 M in MeOH, 50 l, 0.05 mmol) was added to a stirred solution of 24 (14 mg, 0.021 mmol) in MeOH (2.0 ml) at 0 -5 °C, followed by being stirred at room temperature overnight. The mixture was neutralized by Dowex 50X8. After filtering the resin, the filtrate was concentrated in vacuo to give the desired product (III) (9.1 mg, 96%). 
